{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:37:18Z","timestamp":1790861838499,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.pnpbp.2008.07.009","type":"journal-article","created":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T09:18:52Z","timestamp":1216372732000},"page":"1722-1727","source":"Crossref","is-referenced-by-count":79,"title":["Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment"],"prefix":"10.1016","volume":"32","author":[{"given":"S\u00e9verine","family":"Crettol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Besson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Croquette-Krokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"H\u00e4mmig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Gothuey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Monnat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"D\u00e9glon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Preisig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin B.","family":"Eap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2008.07.009_bib1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.drugalcdep.2005.11.024","article-title":"Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis","volume":"83","author":"Arias","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ajmg.b.30319","article-title":"Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments","volume":"141B","author":"Barratt","year":"2006","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib3","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1074\/jbc.M006352200","article-title":"A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling","volume":"276","author":"Befort","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.mp.4000331","article-title":"Mu opioid receptor gene variants: lack of association with alcohol dependence","volume":"2","author":"Bergen","year":"1997","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/alcalc\/agl043","article-title":"The Taqi DRD2 A1 allele is associated with alcohol-dependence although its effect size is small","volume":"41","author":"Berggren","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF02190738","article-title":"Methadone maintenance treatment: an update","volume":"245","author":"Bertschy","year":"1995","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1471-4159.2004.02340.x","article-title":"Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor","volume":"89","author":"Beyer","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.2000.10736099","article-title":"Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors","volume":"32","author":"Blum","year":"2000","journal-title":"J Psychoact Drugs"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib9","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","article-title":"Single-nucleotide polymorphism in the human mu opioid receptor gene alters b-endorphin binding and activity: possible implications for opiate addiction","volume":"95","author":"Bond","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.mp.4000207","article-title":"Studies of the potential role of the dopamine d-1 receptor gene in addictive behaviors","volume":"2","author":"Comings","year":"1997","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.clpt.2006.09.012","article-title":"ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment","volume":"80","author":"Crettol","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/hmg\/ddg055","article-title":"Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor","volume":"12","author":"Duan","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib13","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib14","doi-asserted-by":"crossref","first-page":"RC224","DOI":"10.1523\/JNEUROSCI.22-10-j0004.2002","article-title":"Failure of intravenous morphine to serve as an effective instrumental reinforcer in dopamine D2 receptor knock-out mice","volume":"22","author":"Elmer","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib15","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/(SICI)1096-8628(19991015)88:5<462::AID-AJMG4>3.0.CO;2-S","article-title":"Human delta-opioid receptor gene and susceptibility to heroin and alcohol dependence.","volume":"88B","author":"Franke","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib16","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/sj.mp.4001561","article-title":"C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo","volume":"9","author":"Hirvonen","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-200201000-00001","article-title":"A polymorphism (A118G) in the mu-opioid receptor gene affects the response to morphine-6-glucuronide in humans","volume":"12","author":"H\u00f6llt","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.bbrc.2007.04.074","article-title":"5\u2032 UTR polymorphism of dopamine receptor D1 (DRD1) associated with severity and temperament of alcoholism","volume":"357","author":"Kim","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib19","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1399-6576.2004.00517.x","article-title":"The 118 A>G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease","volume":"48","author":"Klepstad","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.57.1.1","article-title":"Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments","volume":"57","author":"Kreek","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/1096-8628(20001009)96:5<592::AID-AJMG3>3.0.CO;2-Y","article-title":"The D2 dopamine receptor A1 allele and opioid dependence: association with heroin use and response to methadone treatment","volume":"96B","author":"Lawford","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ajmg.10200","article-title":"Allelic association analysis of the dopamine D2, D3, 5-HT2A, and GABA(A)gamma2 receptors and serotonin transporter genes with heroin abuse in Chinese subjects","volume":"114B","author":"Li","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib23","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/01.ALC.0000081624.57507.87","article-title":"Association between dopamine receptor D1 gene DdeI polymorphism and sensation seeking in alcohol-dependent men","volume":"27","author":"Limosin","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molmed.2004.12.006","article-title":"Are mu-opioid receptor polymorphisms important for clinical opioid therapy?","volume":"11","author":"L\u00f6tsch","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008571-200201000-00002","article-title":"The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine","volume":"12","author":"L\u00f6tsch","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clpt.2005.09.010","article-title":"Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action","volume":"79","author":"L\u00f6tsch","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib27","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/41567","article-title":"Absence of opiate rewarding effects in mice lacking dopamine D2 receptors","volume":"388","author":"Maldonado","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.fpc.0000182781.87932.0d","article-title":"Pharmacogenetics of opioid receptors and addiction","volume":"16","author":"Mayer","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib29","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1097\/00001756-199707280-00025","article-title":"Association between a delta opioid receptor gene polymorphism and heroin dependence in man","volume":"8","author":"Mayer","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib30","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/humu.20039","article-title":"Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1","volume":"23","author":"Neville","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ajmg.b.10005","article-title":"D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes","volume":"116B","author":"Noble","year":"2003","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archpsyc.1994.03950110009002","article-title":"Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative","volume":"51","author":"Nurnberger","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.fpc.0000220566.90466.a2","article-title":"The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers","volume":"16","author":"Oertel","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib34","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0006-3223(95)00483-1","article-title":"D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers","volume":"40","author":"Persico","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00000542-200503000-00008","article-title":"Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response","volume":"102","author":"Romberg","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0741-8329(01)00139-2","article-title":"Genetic analysis of the mu-opioid receptor in alcohol-dependent individuals","volume":"24","author":"Rommelspacher","year":"2001","journal-title":"Alcohol"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib37","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1530-0277.1999.tb04157.x","article-title":"Lack of an allelic association between polymorphisms of the dopamine D2 receptor gene and alcohol dependence in the German population","volume":"23","author":"Sander","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajmg.b.30117","article-title":"Association between the DRD2 A1 allele and opium addiction in the Iranian population","volume":"134B","author":"Shahmoradgoli","year":"2005","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0306-4530(99)00017-7","article-title":"Mu-opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal","volume":"24","author":"Smolka","year":"1999","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib40","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1176\/ajp.156.9.1440","article-title":"Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels","volume":"156","author":"Volkow","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/syn.10137","article-title":"Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study","volume":"46","author":"Volkow","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-2999(00)00815-3","article-title":"Polymorphisms in dopamine receptors: what do they tell us?","volume":"410","author":"Wong","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib43","series-title":"A reference model for Schedules for assessment in Neuropsychiatry (SCAN)","author":"World Health Organization G: Diagnosis and clinical measurement in Psychiatry","year":"1992"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajmg.10374","article-title":"Relationship of the delta-opioid receptor gene to heroin abuse in a large Chinese case\/control sample","volume":"110","author":"Xu","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib45","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archpsyc.61.6.597","article-title":"Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations","volume":"61","author":"Xu","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib46","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.addbeh.2004.06.012","article-title":"Advances in molecular genetics and the prevention and treatment of substance misuse: implications of association studies of the A1 allele of the D2 dopamine receptor gene","volume":"29","author":"Young","year":"2004","journal-title":"Addict Behav"},{"key":"10.1016\/j.pnpbp.2008.07.009_bib47","doi-asserted-by":"crossref","first-page":"32618","DOI":"10.1074\/jbc.M504942200","article-title":"Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G","volume":"280","author":"Zhang","year":"2005","journal-title":"J Biol Chem"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608002261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608002261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T06:50:51Z","timestamp":1684479051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584608002261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0278584608002261"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2008.07.009","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}